These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36099411)

  • 1. Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT
    Poulie CBM; Pottie E; Simon IA; Harpsøe K; D'Andrea L; Komarov IV; Gloriam DE; Jensen AA; Stove CP; Kristensen JL
    J Med Chem; 2022 Sep; 65(18):12031-12043. PubMed ID: 36099411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective 5-HT
    Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
    Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT
    Pottie E; Dedecker P; Stove CP
    Biochem Pharmacol; 2020 Dec; 182():114251. PubMed ID: 32998000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
    de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
    ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT
    Pottie E; Poulie CBM; Simon IA; Harpsøe K; D'Andrea L; Komarov IV; Gloriam DE; Jensen AA; Kristensen JL; Stove CP
    ACS Chem Neurosci; 2023 Aug; 14(15):2727-2742. PubMed ID: 37474114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
    Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
    Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
    Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of
    Jensen AA; McCorvy JD; Leth-Petersen S; Bundgaard C; Liebscher G; Kenakin TP; Bräuner-Osborne H; Kehler J; Kristensen JL
    J Pharmacol Exp Ther; 2017 Jun; 361(3):441-453. PubMed ID: 28360333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective 5-HT2A receptor agonist 25CN-NBOH does not affect reversal learning in mice.
    Odland AU; Kristensen JL; Andreasen JT
    Behav Pharmacol; 2021 Aug; 32(5):448-452. PubMed ID: 33595957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 25CN-NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor.
    Märcher Rørsted E; Jensen AA; Kristensen JL
    ChemMedChem; 2021 Nov; 16(21):3263-3270. PubMed ID: 34288515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
    Halberstadt AL; Chatha M; Klein AK; McCorvy JD; Meyer MR; Wagmann L; Stratford A; Brandt SD
    Neuropharmacology; 2020 Aug; 172():107856. PubMed ID: 31756337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 5-HT
    Wallach J; Cao AB; Calkins MM; Heim AJ; Lanham JK; Bonniwell EM; Hennessey JJ; Bock HA; Anderson EI; Sherwood AM; Morris H; de Klein R; Klein AK; Cuccurazzu B; Gamrat J; Fannana T; Zauhar R; Halberstadt AL; McCorvy JD
    Nat Commun; 2023 Dec; 14(1):8221. PubMed ID: 38102107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT
    M Ro Rsted E; Jensen AA; Smits G; Frydenvang K; Kristensen JL
    J Med Chem; 2024 May; 67(9):7224-7244. PubMed ID: 38648420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
    Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of a Hallucinogen-Activated Gq-Coupled 5-HT
    Kim K; Che T; Panova O; DiBerto JF; Lyu J; Krumm BE; Wacker D; Robertson MJ; Seven AB; Nichols DE; Shoichet BK; Skiniotis G; Roth BL
    Cell; 2020 Sep; 182(6):1574-1588.e19. PubMed ID: 32946782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hallucinogens and Serotonin 5-HT
    López-Giménez JF; González-Maeso J
    Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Selective" serotonin 5-HT
    Casey AB; Cui M; Booth RG; Canal CE
    Biochem Pharmacol; 2022 Jun; 200():115028. PubMed ID: 35381208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.
    Fantegrossi WE; Gray BW; Bailey JM; Smith DA; Hansen M; Kristensen JL
    Psychopharmacology (Berl); 2015 Mar; 232(6):1039-47. PubMed ID: 25224567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based discovery of nonhallucinogenic psychedelic analogs.
    Cao D; Yu J; Wang H; Luo Z; Liu X; He L; Qi J; Fan L; Tang L; Chen Z; Li J; Cheng J; Wang S
    Science; 2022 Jan; 375(6579):403-411. PubMed ID: 35084960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD.
    Cao C; Barros-Álvarez X; Zhang S; Kim K; Dämgen MA; Panova O; Suomivuori CM; Fay JF; Zhong X; Krumm BE; Gumpper RH; Seven AB; Robertson MJ; Krogan NJ; Hüttenhain R; Nichols DE; Dror RO; Skiniotis G; Roth BL
    Neuron; 2022 Oct; 110(19):3154-3167.e7. PubMed ID: 36087581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.